From: Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
Parameter
Onset during surgery
Onset 24–48 h postop
Onset 72–96 h postop
All patients (n = 56)
5 (8.9)
4 (7.1)
2 (3.6)
Landiolol (n = 28)
3 (10.7)
0 (0.0)
Placebo (n = 28)
2 (7.1)
1 (3.6)